PHILADELPHIA – Healthcare IT firm Greenphire announced today that it has formed an exclusive strategic partnership with the clinical trials division of Merge Healthcare, a provider of clinical trial solutions, to offer integrated functionality between Merge’s EDC technology and Greenphire’s eClinicalGPS site and vendor payment management technology.
The integrated EDC and payment technology offering will enable both companies' pharmaceutical, medical device and clinical research organization (CRO) clients to further automate and centrally track all clinical payments on a global basis.
“Our alliance with Merge enables us to collaboratively bring an innovative and complementary set of technologies to the clinical research industry, driving additional efficiency to sponsors, CROs and sites on a global basis,” said Greenphire CEO Sam Whitaker.
The functionality achieved through this strategic partnership will streamline implementation processes and create additional efficiencies for clients, enabling users to automate research site and clinical vendor payments in local currency through Greenphire's centralized, global web-based payment engine, the company said in a press release.
Additionally, it will streamline setup times, decrease sponsor, site and CRO administrative burdens on an on-going basis, reduce payment administration costs and timelines, and increase site satisfaction, according to the press release.
“This partnership demonstrates that Merge is committed to addressing the needs of our clinical trials customers, specifically those who have asked for an integrated site payment system for their clinical programs,” said Jeff Surges, CEO of Merge Healthcare.
